We are live on ! Find out more
Focus Partners Wealth

Focus Partners Wealth Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.5%
This Fund
S&P 500
This Quarter Est. Return
+9.3%
1 Year Est. Return
+20.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$46.2B
AUM Growth
+$6.25B
Cap. Flow
+$3.01B
Cap. Flow %
6.53%
Top 10 Hldgs %
20.21%
Holding
2,150
New
257
Increased
1,144
Reduced
554
Closed
122

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.18%
3 Consumer Discretionary 4.62%
4 Communication Services 3.84%
5 Healthcare 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PSNL icon
1951
Personalis
PSNL
$1.26B
$88.7K ﹤0.01%
13,527
BEEP icon
1952
Mobile Infrastructure Corp
BEEP
$71.3M
$86.6K ﹤0.01%
19,110
HCAT icon
1953
Health Catalyst
HCAT
$154M
$84.9K ﹤0.01%
22,515
+12,317
+121% +$48.5K
BBBY
1954
Bed Bath & Beyond
BBBY
$473M
$83.7K ﹤0.01%
13,375
-863
-6% -$4.18K
SANA icon
1955
Sana Biotechnology
SANA
$885M
$82.8K ﹤0.01%
30,319
+4,994
+20% +$10.3K
NXDR
1956
Nextdoor Holdings
NXDR
$835M
$79.9K ﹤0.01%
48,112
+13,352
+38% +$20.1K
PFN
1957
PIMCO Income Strategy Fund II
PFN
$695M
$77.7K ﹤0.01%
+10,515
New +$76K
PTON icon
1958
Peloton Interactive
PTON
$2.63B
$75.5K ﹤0.01%
10,885
-8,737
-45% -$56.8K
CFFN icon
1959
Capitol Federal Financial
CFFN
$1.08B
$73.9K ﹤0.01%
+12,117
New +$68.6K
UP icon
1960
Wheels Up
UP
$220M
$73.2K ﹤0.01%
3,420
+35
+1% +$860
RXRX icon
1961
Recursion Pharmaceuticals
RXRX
$1.57B
$72.6K ﹤0.01%
14,340
-214
-1% -$1.05K
GAB icon
1962
Gabelli Equity Trust
GAB
$1.74B
$70.9K ﹤0.01%
12,190
-9,715
-44% -$54.1K
MIST icon
1963
Milestone Pharmaceuticals
MIST
$144M
$69.8K ﹤0.01%
+36,000
New +$48K
RLAY icon
1964
Relay Therapeutics
RLAY
$4.02B
$68K ﹤0.01%
+19,647
New +$58.4K
NGD
1965
DELISTED
New Gold Inc
NGD
$64.6K ﹤0.01%
13,052
+494
+4% +$2.03K
ANIX icon
1966
Anixa Biosciences
ANIX
$126M
$60.2K ﹤0.01%
18,243
-53,559
-75% -$153K
BLND icon
1967
Blend Labs
BLND
$409M
$60.2K ﹤0.01%
+18,237
New +$61.8K
RIG icon
1968
Transocean
RIG
$5.92B
$58.9K ﹤0.01%
22,731
+8,931
+65% +$23K
GLUE icon
1969
Monte Rosa Therapeutics
GLUE
$1.92B
$57.7K ﹤0.01%
12,789
+801
+7% +$3.57K
TROX icon
1970
Tronox
TROX
$995M
$57.5K ﹤0.01%
+11,335
New +$61.7K
ABUS icon
1971
Arbutus Biopharma
ABUS
$865M
$55.1K ﹤0.01%
17,821
-191
-1% -$634
ARDX icon
1972
Ardelyx
ARDX
$1.24B
$54.6K ﹤0.01%
13,935
-695
-5% -$2.87K
WOOF icon
1973
Petco
WOOF
$745M
$54.6K ﹤0.01%
19,287
+6,285
+48% +$19.5K
TSI
1974
TCW Strategic Income Fund
TSI
$212M
$50.7K ﹤0.01%
10,275
PLUG icon
1975
Plug Power
PLUG
$2.92B
$50.5K ﹤0.01%
33,900
+6,333
+23% +$6.32K

Similar funds

Focus Partners Wealth's Q2 2025 Portfolio in Review

As of Q2 2025, Focus Partners Wealth held 2,150 positions worth $46.2B, up 16% from $39.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Focus Partners Wealth deployed $3.01B of net new capital in Q2 2025, opening 257 new positions and adding to 1,144 existing holdings. Its largest new stake was CCC Intelligent Solutions: 4,486,286 shares worth $42.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $209M trimmed.

  • Focus Partners Wealth's largest Q2 2025 buy was CCC Intelligent Solutions: 4,486,286 shares worth $42.2M.
  • Focus Partners Wealth added most to Dimensional US High Profitability ETF in Q2 2025, an estimated $234M increase.
  • Focus Partners Wealth's biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $209M.
  • Focus Partners Wealth fully exited Cass Information Systems in Q2 2025, selling an estimated $33M.
  • Focus Partners Wealth's ten largest holdings make up 20% of its $46.2B portfolio in Q2 2025.
  • Focus Partners Wealth opened 257 new positions and closed 122 in Q2 2025.
  • Focus Partners Wealth's portfolio value rose 16% quarter-over-quarter to $46.2B.

Based on Focus Partners Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.